Condition: Diphtheria · Tetanus · Pertussis · Sponsor: LG Chem
The purpose of this study is to evaluate immunogenicity, safety and lot-to-lot consistency of LBVD in comparison to co-administration of Pentavalent vaccine and Poliomyelitis Vaccine (Inactivated) in separate injections at four weeks after completion of three-dose primary series at 6-10-14 weeks of age when administered to healthy infants
This description comes directly from the study's public registry record.
Clinical Study Lead · +82-2-6987-4156 · lgclinical@lgchem.com
Always discuss trial participation with your own doctor first.
| Care CT Group | Dasmariñas, Cavite, Philippines | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06947499